Individuals who form kidney stones are at increased risk for myocardial infarction (MI) independent of CKD and other risk factors, according to researchers.

Active surveillance may be a suitable option for many men with low-risk prostate cancer (PCa), Swedish researchers concluded.

SAN FRANCISCO—Initiating statin therapy after radical prostatectomy (RP) may decrease the risk of biochemical recurrence of prostate cancer, new data suggest.

CHICAGO—Tasquinimod, a novel biologic agent, may significantly slow the rate of disease progression and improve progression-free survival in patients with metastatic castrate-resistant prostate cancer (CRCP), according to a new study presented at the American Society of Clinical Oncology annual meeting.

A study of patients seeking care at an inner-city clinic showed that higher levels of alkaline phosphatase and phosphate are associated with increased mortality.

Patients with both heart disease and CKD experience decreased risk of cardiovascular events.

NEW YORK—New findings suggest that electronic health records (EHR) with special features for managing hypertension may be highly beneficial in improving BP control.

These devices improved patient quality of life significantly better than conventional plastic stents.

BARCELONA—Researchers have documented a small but significant stage migration in metastatic bladder cancer between 1988 and 2006.

Higher serum uric acid (SUA) levels may independently contribute to the development of CKD, data suggest.